Adding Phosphate as a ‘uranium Getter’ in Hydrothermal Bentonite Experiments

Caporuscio, Florie; Sauer, Kirsten; Rock, Marlena

doi:10.46427/gold2020.319

Goldschmidt Abstracts 2020

DOI: 10.46427/gold2020.319

|View full text |Cite

Adding Phosphate as a ‘uranium Getter’ in Hydrothermal Bentonite Experiments

Florie Caporuscio¹,

Kirsten Sauer²,

Marlena Rock³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This dose is lower than the 20-mg/kg dose of CBD administered for the control of seizures in children and young adults with Dravet syndrome and corresponds with the lower end of the range of concentrations of CBD (0.10 mg/mL-655.27 mg/mL) observed in a sample of CBD extracts sold online . Although there are too few studies on which to base dosing of CBD, and therefore no authoritative source, social media and other posted recommendations include doses of 600 mg per day, and a recent phase 2 study of CBD to treat cannabis use disorder suggested efficacy for 800 mg daily, well above the 14-mg dose tested by Arkell et al…”

mentioning

confidence: 97%

Cannabis and Impaired Driving

Cole¹,

Saitz

2020

JAMA

View full text Add to dashboard Cite

Impaired driving is a major cause of preventable death worldwide. Alcohol-impaired driving accounted for a mean of 19% (range, 3%-34%) of the motor vehicle crash deaths in 20 countries in 2016 1 ; in 2018, 29% of the 36 560 crash deaths in the US were attributed to impaired driving. 2 By comparison, driving under the influence of cannabis was estimated to account for 8700 road traffic deaths worldwide in 2013. 3 Alcohol and cannabis are often consumed together, and their combined use is associated with greater crash risk than the use of either substance alone. 3 Notably, cannabinoids are the most commonly detected other drugs (besides alcohol) in fatally injured drivers (up to 15% in urban areas), and the prevalence is increasing. 4,5 Understanding and addressing cannabis-impaired driving has challenges that differ from alcohol-impaired driving. Cannabis is not limited to a single drug. Recreational cannabis generally contains both Δ 9 -tetrahydrocannabinol (THC) and cannabidiol (CBD), among dozens of other cannabinoids. The best evidence for beneficial effects of cannabinoids are for the use of CBD to treat rare pediatric convulsive disorders. 6 A National Academy of Sciences panel cited substantial evidence for modest effects of cannabinoids for chronic pain, nausea and vomiting associated with chemotherapy, and spasticity of multiple sclerosis. 7 However, cannabinoids used for the treatment of disorders and their symptoms are largely pharmaceutical-grade products (ie, not smoked or vaped products) that contain synthetic THC or combinations of THC and CBD. The majority of cannabis products available and used are not specific pharmaceutically prepared cannabinoids in well-studied doses, and dose labels often misrepresent actual contents. Thus, assessing cannabis exposure is complex.Furthermore, unlike alcohol, cannabinoid level does not correspond to performance impairment or perceived intoxication, which may persist long after peak levels can be measured. In addition, when cannabinoids are detected in drivers involved in fatal crashes, other drugs are often also detected. Consumption of THC, which produces short-term intoxication and positive mood, 8 has been demonstrated in laboratory studies to impair motor performance and cognitive function required for safe driving. 3 The effects of CBD, of THC combined with CBD, of cannabinoids with other substances, and the effects of multiple daily doses or repeated long-term cannabinoid use on driving performance are less well-studied.In this issue of JAMA, a crossover clinical trial by Arkell and colleagues 9 tested whether consumption of specific doses of THC and CBD resulted in driving impairment, as measured by

show abstract

mentioning

confidence: 97%

Cannabis and Impaired Driving

Cole¹,

Saitz

2020

JAMA

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Adding Phosphate as a ‘uranium Getter’ in Hydrothermal Bentonite Experiments

Cited by 1 publication

References 0 publications

Cannabis and Impaired Driving

Cannabis and Impaired Driving

Contact Info

Product

Resources

About